Treatment with hydroxychloroquine, azithromycin, and combination in patients hospitalized with COVID-19
The objective of this retrospective observational study was to evaluate the role of hydroxychloroquine therapy alone and in combination with azithromycin in hospitalized patients positive for COVID-19.
According to a protocol-based treatment algorithm, among hospitalized patients, use of hydroxychloroquine alone and in combination with azithromycin was associated with a significant reduction in-hospital mortality compared to not receiving hydroxychloroquine.
0
1
Contributors are:
Who are from:
Tags
SARS-CoV-2 (COVID-19)
Biomedical Sciences
Related
In a French open-label non-randomized clinical trial, more patients treated with hydroxychloroquine+azithromycin tested negative for COVID-19 by day 6 after inclusion in study compared to a control group
In vitro testing revealed synergistic effect of combined hydroxychloroquine (HCQ) and azithromycin (AZM) on SARS-CoV-2
Treatment with hydroxychloroquine, azithromycin, and combination in patients hospitalized with COVID-19
Learn After
Methods for Treatment with hydroxychloroquine, azithromycin, and combination in patients hospitalized with COVID-19
Statistical analysis methods for Treatment with hydroxychloroquine, azithromycin, and combination in patients hospitalized with COVID-19
Results of Treatment with hydroxychloroquine, azithromycin, and combination in patients hospitalized with COVID-19
Discussion for Treatment with hydroxychloroquine, azithromycin, and combination in patients hospitalized with COVID-19